top of page
SEC Enforcement Proceedings
Sec Enforcement News: Protecting Investors From Breaches Of Fiduciary, Disclosure Violations, And Illegal Distributions And Sales Of Restricted Stock
The Securities and Exchange Commission (“SEC”) has been busy so far this spring. In the latest roundup, this Blog looks at enforcement actions taken by the SEC against investment advisors, a medical device company and a purported cryptocurrency company. SEC Charges Medical Device Company and Founder with Fraud for Failing to Make Disclosures and Misappropriating Investor Funds On April 5, 2018, the SEC announced ( here ) that it had charged convicted felon and former NHL te
admin
Apr 11, 20184 min read
SEC ENFORCEMENT NEWS: PROTECTING ADVISORY CLIENTS FROM UNDISCLOSED CONFLICTS OF INTEREST IN THE SALE OF MUTUAL FUND SHARE CLASSES
Ameriprise Settles with The SEC for Overcharging Retirement Account Customers for Mutual Fund Shares On February 28, 2018, just a few weeks after launching its Share Class Selection Disclosure Initiative (discussed below), the Securities and Exchange Commission (“SEC”) announced ( here ) that Ameriprise Financial Services Inc. (“Ameriprise”), the Minnesota-based broker-dealer and investment adviser, agreed to settle charges for recommending and selling higher-fee mutual fund
admin
Mar 7, 20184 min read
U.S. SUPREME COURT TO HEAR ARGUMENT CONCERNING STATUS OF SEC ADMINISTRATIVE JUDGES
On February 23, 2018, the U.S. Supreme Court set oral argument in Lucia v. SEC , 17-130, a case involving the use of administrative law judges (“ALJ”) by the Securities and Exchange Commission (“SEC” or the “Commission”) as hearing officers in administrative proceedings. The issue presented to the Court concerns whether the use of ALJs violates the constitutional limitations of the Appointments Clause on “Officers of the United States” ( here ). U.S. Const., art. II, § 2, cl
admin
Mar 5, 20188 min read
Biotech Company And Former Executives Settle Charges Of Securities And Accounting Fraud
On November 2, 2017, the Securities and Exchange Commission (“SEC” or the “Commission”) announced ( here ) that it had charged Osiris Therapeutics, Inc. (“Osiris” or the “Company”), a Maryland-based biotech company, and four former senior executives with inflating reported revenue growth, improperly recognizing revenue and misleading investors. In its complaint ( here ), the SEC alleged that Osiris routinely overstated Company performance and issued fraudulent financial stat
admin
Nov 13, 20174 min read
SEC Targets ICO Fraud
The SEC recently announced that fraud charges were being brought against the creator of two Initial Coin Offerings (“ICOs”). The complaint alleges that Maksim Zaslavskiy ("Zaslavskiy") defrauded investors with two ICOs, the REcoin Group Foundation, LLC ("REcoin") and the DRC World, Inc. (also known as the Diamond Reserve Club) ("DRC"), that were said to be backed by investments in real estate and diamonds. What is an ICO? ICOs are a way for startups to raise money by issuing
admin
Oct 16, 20173 min read
U.S. Supreme Court Holds That Disgorgement Claims Must Be Commenced Within Five Years Of The Date The Claim Accrued
On June 5, 2017, the U.S. Supreme Court held that claims for disgorgement imposed as a sanction for violation of the federal securities laws must be commenced within five years of the date the claim accrues. In doing so, the Court rejected the SEC’s argument that the five-year statute of limitations was not applicable to claims for disgorgement. The decision, written by Justice Sonia Sotomayor for a unanimous court, resolves a split among the circuits and provides clarity co
admin
Jun 7, 20174 min read
bottom of page
